Cargando…

Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older

Detalles Bibliográficos
Autores principales:	Iversen, Patrick L, Bavari, Sina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376211/ https://www.ncbi.nlm.nih.gov/pubmed/34430953 http://dx.doi.org/10.1016/S2666-7568(21)00205-1

Ejemplares similares

Inactivated COVID-19 vaccines to make a global impact
por: Iversen, Patrick L, et al.
Publicado: (2021)

Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2?
por: Iversen, Patrick L, et al.
Publicado: (2021)

Heterologous vaccine regimens against COVID-19
por: Duarte-Salles, Talita, et al.
Publicado: (2021)

COVID-19 vaccination for children aged 5–11 years
por: Ladhani, Shamez N
Publicado: (2022)

80 years of Netherlands Society of Cardiology
por: Umans, V. A. W. M., et al.
Publicado: (2014)

Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia
por: Wood, Nicholas, et al.
Publicado: (2023)

Herd immunity or health equity? – extending HPV vaccination
por: Keddy, Karen H., et al.
Publicado: (2023)

Age-old musings: twenty-first century management of advanced kidney disease in older individuals
por: Jassal, Sarbjit Vanita, et al.
Publicado: (2021)

Waning of COVID-19 vaccine effectiveness: individual and public health risk
por: Piechotta, Vanessa, et al.
Publicado: (2022)

Age and frailty in COVID-19 vaccine development
por: Andrew, Melissa K, et al.
Publicado: (2021)

COVID-19 vaccines in the age of the delta variant
por: Wheatley, Adam K, et al.
Publicado: (2022)

Assessing the effectiveness of COVID-19 vaccines in older people in Latin America
por: Rodriguez-Morales, Alfonso J, et al.
Publicado: (2022)

Barriers to COVID-19 vaccination among older adults in Mexico City
por: Gaitán-Rossi, Pablo, et al.
Publicado: (2022)

Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
por: Rogawski McQuade, Elizabeth T, et al.
Publicado: (2021)

Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults
por: Cox, Lynne S, et al.
Publicado: (2020)

COVID-19 vaccines for the older population: safety and efficacy go hand in hand
por: Zheng, Hui, et al.
Publicado: (2022)

Willingness to receive the COVID-19 vaccine in the population aged 80 years and older in Colombia 2021()
por: Alvis-Guzman, N., et al.
Publicado: (2022)

Sexuality and sexual activity in older age: an age old issue?
por: Grabovac, Igor, et al.
Publicado: (2023)

Population versus individual protection by pneumococcal conjugate vaccination
por: Klugman, Keith P, et al.
Publicado: (2019)

COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective
por: Loh, Kah Poh, et al.
Publicado: (2021)

Assessment of frailty syndrome with coexisting hypertension and depression among older individuals, aged >80 years of age
por: Avvari, Anugna, et al.
Publicado: (2022)

COVID-19 vaccines for children younger than 12 years: are we ready?
por: Zou, Xiaohui, et al.
Publicado: (2021)

An immunological autobiography: my year as a COVID-19 vaccine trial participant
por: Kedl, Ross M.
Publicado: (2022)

Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021
por: Azzoug, Chana, et al.
Publicado: (2023)

Extending reference assembly models
por: Church, Deanna M, et al.
Publicado: (2015)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

Extending the landscape of omics technologies by pathomics
por: Bülow, Roman D., et al.
Publicado: (2023)

COVID-19 immunisation in older people
por: Vigezzi, Giacomo Pietro, et al.
Publicado: (2022)

COVID-19 related stroke in young individuals
por: Fifi, Johanna T, et al.
Publicado: (2020)

Extending research impact by sharing maker information
por: Howell, Larry L., et al.
Publicado: (2023)

Use of tiotropium in patients with COPD aged 80 years and older
por: SATOH, HIROAKI, et al.
Publicado: (2013)

Serological response to COVID-19 vaccination in patients with cancer older than 80 years
por: Iacono, Daniela, et al.
Publicado: (2021)

Understanding the determinants of acceptance of COVID-19 vaccines: a challenge in a fast-moving situation
por: Verger, Pierre, et al.
Publicado: (2021)

Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

Can extended reality in the metaverse revolutionise health communication?
por: Plechatá, Adéla, et al.
Publicado: (2022)

Are older people with disabilities neglected in the COVID-19 pandemic?
por: Kuper, Hannah, et al.
Publicado: (2021)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1p9b5pt5lcvjjq7q585g4gff02